Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: Protocol for a prospective cohort study

BMC Geriatrics

Volumn 9, Issue 1, 2009, Pages

  Morris, Meg E ^a   Watts, Jennifer J ^a,b   Iansek, Robert ^b,c   Jolley, Damien ^b   Campbell, Donald ^b   Murphy, Anna T ^a,b,c   Martin, Clarissa L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Kingston Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; ECONOMICS; HEALTH STATUS; HUMAN; METHODOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; HEALTH STATUS; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 61649122623     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-9-2     Document Type: Article

References (29)

1. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. ER Dorsey R Constantinescu JP Thompson KM Biglan RG Holloway K Kieburtz FJ Marshall BM Ravina G Schifitto A Siderowf CM Tanner, Neurology 2007 68 5 384 386 10.1212/01.wnl.0000247740.47667.03 17082464
2. Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study. LM de Lau PC Giesbergen MC de Rijk A Hofman PJ Koudstaal MM Breteler, Neurology 2004 63 7 1240 1244 15477545
3. Australian Institute of Health and Welfare. http://www.aihw.gov.au/ publications/aus/ah06/ah06-c03.pdf
4. Cost of Parkinson's disease in Europe. P Lindgren S von Campenhausen E Spottke U Siebert R Dodel, European Journal of Neurology 2005 12 68 73 15877783 10.1111/j.1468-1331.2005.01197.x
5. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia. DJ Cordato R Schwartz E Abbott R Saunders L Morfis, Journal of Clinical Neuroscience 2006 13 6 655 658 10.1016/j.jocn.2005.09.006 16797991
6. The Economic Impact of Parkinson's Disease: An Estimation Based on a 3-Month Prospective Analysis. RC Dodel M Singer R Kahne-Volland T Szucs B Rathay E Scholz WH Oertel, PharmacoEconomics 1998 14 3 299 312 10.2165/00019053- 199814030-00006 10186468
7. Direct economic impact of Parkinson's disease: A research survey in the United Kingdom. L Findley M Aujla PG Bain M Baker C Beech C Bowman J Holmes WK Kingdom DG MacMahon V Peto JR Playfer, Movement Disorders 2003 18 10 1139 1145 10.1002/mds.10507 14534917
8. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. P Hagell S Nordling J Reimer M Grabowski U Persson, Movement Disorders 2002 17 6 1213 1220 10.1002/mds.10262 12465059
9. Physiology of basal ganglia disorders: an overview. M Hallett, Can J Neurol Sci 1993 20 3 177 183 8221380
10. Pathophysiology of bradykinesia in Parkinson's disease. A Berardelli JC Rothwell PD Thompson M Hallett, Brain 2001 124 2131 2146 10.1093/brain/124.11. 2131 11673316
11. The pathogenesis of gait hypokinesia in Parkinson's disease. ME Morris R Iansek TA Matyas JJ Summers, Brain 1994 117 Pt 5 1169 1181 10.1093/brain/117.5. 1169 7953597
12. Motor function of the monkey globus pallidus. Cognitive aspects of movement and phasic neuronal activity. P Brotchie R Iansek MK Horne, Brain 1991 114 Pt 4 1685 1702 10.1093/brain/114.4.1685 1884173
13. Characteristics of motor disturbance in Parkinson's disease and strategies for movement rehabilitation. ME Morris R Iansek, Journal of Human Movement Science 1996 15 649 669 10.1016/0167-9457(96)00020-6
14. Pharmacological management of Parkinson's disease. R Iansek, Geriatric Therapeutics 2004 34 229 232
15. The spectrum of levodopa-induced dyskinesias. S Fahn JA Obeso CW Olanow A Lang E Tison Marion, Ann Neurol 2000 47 4 Suppl 1 S2 S9 10762127
16. Occupational therapy for people with Parkinson's disease. B Kirkwood, Parkinson's disease: A team approach Victoria: Biscombe Vicprint, Morris M, Iansek R, 1997
17. Efficacy of a physical therapy program in patients with Parkinson's disease: a randomised controlled trial. T Ellis C de Goede RG Feldman EC Wolters G Kwakkel RC Wagenaar, Archives of Physical Medicine & Rehabilitation 2005 86 626 632 10.1016/j.apmr.2004.08.008
18. Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. DT Wade H Gage C Owen P Trend C Grossmith J Kaye, Journal of Neurology, Neurosurgery & Psychiatry 2003 74 158 162 10.1136/jnnp.74.2.158
19. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's diseas and their carers. P Trend J Kaye H Gage C Owen DT Wade, Clinical Rehabilitation 2002 16 717 725 10.1191/0269215502cr545oa 12428820
20. Impairments, activity limitations and participation restrictions in Parkinson's disease. ME Morris, Science-based rehabilitation: theories into practice Butterworth Heinemann: London, Refshauge K, Ada L, Ellis E, 2005
21. The effects of physical therapy in Parkinson's disease: a research synthesis. CJ de Goede SH Keus G Kwakkel RC Wagenaar, Arch Phys Med Rehabil 2001 82 4 509 515 10.1053/apmr.2001.22352 11295012
22. Parkinsonism: onset, progression and mortality. MM Hoehn MD Yahr, Neurology 1967 17 5 427 442 6067254 10.1159/000137111
23. Measuring gait and gait-related activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. LI Lim EE van Wegen CJ de Goede D Jones L Rochester V Hetherington A Nieuwboer AM Willems G Kwakkel, Parkinsonism & Related Disorders 2005 11 1 19 24 10.1016/j.parkreldis.2004.06.003 15619458
24. Attending to the task: Interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue and balance. L Rochester V Hetherington D Jones A Nieuwboer AM Willems G Kwakkel E Van Wegen, Archives of Physical Medicine & Rehabilitation 2004 85 1578 1585 10.1016/j.apmr.2004.01.025
25. Gait and balance in basal ganglia disorders. BR Bloem KP Bhatia, Clinical Disorders of Balance, Posture, and Gait. Gait and balance in basal ganglia disorders London: Arnold, Bronstein A, Brandt T, Woollacott M, Nutt JG, 2004 13 206
26. Movement Disorders 2. CD Marsden S Fahn (eds), London: Butterworth & Co. Ltd 1987
27. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. CG Goetz GT Stebbins HM Shale, Movement Disorders 1994 9 390 394 10.1002/mds.870090403 7969204
28. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. V Peto C Jenkinson R Fitzpatrick R Greenhall, Qual Life Res 1967 4 3 441 448 7613534
29. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. D Podsiadlo S Richardson, Journal of the American Geriatrics Society 1991 39 2 142 148 1991946